John Reed
Tracked across 1 events · 13 articles · First seen Jun 08, 2026 · Last active Jun 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: John Reed, Executive Vice President of Innovative Medicine, Research & Development at Johnson & Johnson, commented on the significance of the Firelink platform in addressing KRAS-driven cancers, emphasizing the strategic importance of the acquisition.
Jun 08, 2026 · 13 articles
ERGEN INTELLIGENCE
Track John Reed live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard